June 22, 2017
Sponsored by
Illumina

NGS-Based Molecular Tumor Profiling to Advance Clinical Cancer Research

GenomeWebinar

Faculty Investigator, Hudson Alpha Institute for Biotechnology:

Global Senior Product Manager, Oncology, Illumina

This webinar describes one institution’s approach to broad molecular profiling of tumor samples using Next-Generation Sequencing (NGS).

The promise of precision oncology can only be realized when the genetic basis of each tumor sample is fully understood. However, the list of genes that can contribute to tumor progression and, subsequently, inform the therapeutic course of action for a given patient, continues to grow. Furthermore, the function of any gene can be altered by several types of variations, including single nucleotide variants, multiple nucleotide variants, small insertions or deletions, copy number variants, splice variations, and gene fusions. Therefore, it is difficult for researchers to analyze tumors efficiently when available methods only cover a portion of these variations, and sequential analysis consumes valuable tissue, time, and resources. Only when these barriers can be overcome can the application of NGS in clinical cancer research be fully evaluated.

In this webinar, Devin Absher from the Hudson Alpha Institute for Biotechnology discusses how his team is leveraging NGS assays to evaluate the potential of NGS in precision oncology. Dr. Absher discusses his team's approach to cancer research and offer case studies showing results of recent studies.

Sponsored by

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Sep
07
Sponsored by
PerkinElmer

This webinar will address improvements in the library prep workflow for small RNA sequencing in serum and plasma.

Sep
20
Sponsored by
Ion Torrent

This webinar will discuss how next-generation sequencing (NGS) can help clinical research labs and pathologists save time, money, and samples compared to single-analyte oncology research assays.

Sep
21
Sponsored by
Roche

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.

Sep
26
Sponsored by
PerkinElmer

This webinar will describe a protocol and proof-of-principle experiments for Cellular Indexing of Transcriptome and Epitopes by Sequencing (CITE-seq).